loader
Please Wait
Applying Filters...
Close
4

Bora CDMO Bora CDMO

X

List of Remimazolam NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Wavelength Enterprises Ltd (1)

02 Patheon Italia S.p.A. (1)

filter

01 Remimazolam Besylate (1)

02 remimazolam besylate (1)

filter

01 France (1)

02 U.S.A (1)

Remimazolam Besylate
POWDER (1kg/kg)
BULK INGREDIENT
58175-0648
2022-08-31
2023-12-31
URL Supplier Web Content
remimazolam besylate
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (2.5mg/mL)
DRUG FOR FURTHER PRO...
68225-120
2020-07-02
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 308242-62-8 / Remimazolam API manufacturers, exporters & distributors?

Remimazolam manufacturers, exporters & distributors 1

55

PharmaCompass offers a list of Remimazolam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Remimazolam manufacturer or Remimazolam supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Remimazolam manufacturer or Remimazolam supplier.

PharmaCompass also assists you with knowing the Remimazolam API Price utilized in the formulation of products. Remimazolam API Price is not always fixed or binding as the Remimazolam Price is obtained through a variety of data sources. The Remimazolam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Remimazolam

Synonyms

308242-62-8, Cns 7056, Cns-7056, Ono-2745, 7v4a8u16mb, 308242-62-8 (freee base)

Cas Number

308242-62-8

Unique Ingredient Identifier (UNII)

7V4A8U16MB

About Remimazolam

Remimazolam is a short-acting benzodiazepine derivative that is structurally related to midazolam, with sedative-hypnotic activity. Upon administration, remimazolam targets and binds to a specific site on the gamma-aminobutyric acid (GABA)-A-chloride ionophore receptor complex located on the neuronal membrane. Binding causes an allosteric modification of the receptor thereby enhancing the affinity of GABA to the receptor leading to an increase in the frequency of chloride-channel opening events, which leads to an increase in chloride ion conductance, neuronal hyperpolarization, inhibition of the action potential, and a decrease in neuronal excitability.

Remimazolam Manufacturers

A Remimazolam manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Remimazolam, including repackagers and relabelers. The FDA regulates Remimazolam manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Remimazolam API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Remimazolam manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Remimazolam Suppliers

A Remimazolam supplier is an individual or a company that provides Remimazolam active pharmaceutical ingredient (API) or Remimazolam finished formulations upon request. The Remimazolam suppliers may include Remimazolam API manufacturers, exporters, distributors and traders.

click here to find a list of Remimazolam suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Remimazolam NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Remimazolam as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Remimazolam API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Remimazolam as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Remimazolam and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Remimazolam NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Remimazolam suppliers with NDC on PharmaCompass.

Remimazolam Manufacturers | Traders | Suppliers

Remimazolam Manufacturers, Traders, Suppliers 1
30

We have 2 companies offering Remimazolam

Get in contact with the supplier of your choice:

  1. Seqens
  2. Patheon
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY